PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 92 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334 | +80.5% | 1,120 | 0.0% | 0.00% | – |
| Q2 2023 | $185 | -83.1% | 1,120 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,093 | -45.4% | 1,120 | -41.8% | 0.00% | 0.0% |
| Q4 2022 | $2,000 | 0.0% | 1,923 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | -50.0% | 1,923 | -10.2% | 0.00% | -50.0% |
| Q2 2022 | $4,000 | -20.0% | 2,142 | +60.0% | 0.00% | -33.3% |
| Q4 2021 | $5,000 | -28.6% | 1,339 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $7,000 | +40.0% | 1,339 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $5,000 | +66.7% | 1,339 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $3,000 | +200.0% | 1,339 | +79.3% | 0.00% | +100.0% |
| Q4 2020 | $1,000 | -50.0% | 747 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $2,000 | -50.0% | 747 | -43.0% | 0.00% | -33.3% |
| Q3 2019 | $4,000 | -42.9% | 1,311 | -9.1% | 0.00% | -40.0% |
| Q2 2019 | $7,000 | +40.0% | 1,442 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $5,000 | -37.5% | 1,442 | -3.4% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | – | 1,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |